SMTL ID : 5p9n.1

humanized rat COMT in complex with 5-(4-fluorophenyl)-2,3-dihydroxy-N-[[3-[hydroxy-(1-methylindazol-5-yl)methyl]phenyl]methyl]benzamide at 1.17A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.17 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 6 residues within 4Å: Chain A: D.141, K.144, D.169, N.170 Ligands: 7JE.7, 8JE.8 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.141, A:D.169, H2O.1

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 4 residues within 4Å: Chain A: N.41, V.42, Y.71, S.72 Ligand excluded by PLIP CL.3: 3 residues within 4Å: Chain A: D.44, A.45, Y.200 Ligand excluded by PLIP

1 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)

NHE.4: 6 residues within 4Å: Chain A: E.37, W.38, M.201 Ligands: D1D.5, 7JE.7, 8JE.8 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.38 Hydrogen bonds: A:W.38

1 x D1D: (4S,5S)-1,2-DITHIANE-4,5-DIOL(Non-covalent)

D1D.5: 6 residues within 4Å: Chain A: W.38, L.198, M.201 Ligands: NHE.4, 7JE.7, 8JE.8 No protein-ligand interaction detected (PLIP)

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.6: 4 residues within 4Å: Chain A: P.82, G.83, R.85, K.111 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.83 Water bridges: A:A.84, A:R.85 Salt bridges: A:R.85, A:K.111

1 x 7JE: 5-(4-fluorophenyl)-~{N}-[[3-[(~{R})-(1-methylindazol-5-yl)-oxidanyl-methyl]phenyl]methyl]-2,3-bis(oxidanyl)benzamide(Non-covalent)

7JE.7: 26 residues within 4Å: Chain A: W.38, M.40, G.66, Y.68, M.89, E.90, I.91, G.117, A.118, S.119, Q.120, D.141, H.142, W.143, K.144, R.146, D.169, N.170, V.173, P.174, L.198, E.199 Ligands: MG.1, NHE.4, D1D.5, 8JE.8 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:M.40, A:I.91, A:H.142, A:V.173, A:P.174, A:L.198, A:L.198 Hydrogen bonds: A:Y.68, A:S.119, A:D.141, A:D.141, A:K.144, A:N.170, A:E.199 pi-Stacking: A:W.38, A:H.142, A:W.143, A:W.143

1 x 8JE: 5-(4-fluorophenyl)-~{N}-[[3-[(~{S})-(1-methylindazol-5-yl)-oxidanyl-methyl]phenyl]methyl]-2,3-bis(oxidanyl)benzamide(Non-covalent)

8JE.8: 26 residues within 4Å: Chain A: W.38, M.40, G.66, M.89, E.90, I.91, N.92, G.117, A.118, S.119, Q.120, D.141, H.142, W.143, K.144, R.146, D.169, N.170, V.173, P.174, L.198, E.199 Ligands: MG.1, NHE.4, D1D.5, 7JE.7 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:M.40, A:I.91, A:H.142, A:V.173, A:P.174, A:L.198, A:L.198 Hydrogen bonds: A:S.119, A:D.141, A:D.141, A:K.144, A:N.170, A:E.199 pi-Stacking: A:W.38, A:H.142, A:W.143, A:W.143

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lerner, C. et al., Crystal Structure of a COMT complex. To be published

Release Date

2017-11-22

Peptides

Catechol O-methyltransferase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Catechol O-methyltransferase

Related Entries With Identical Sequence